Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery, identifying genetic connections between inflammatory bowel disease (IBD) and Parkinson’s disease (PD).
Updated: ‘Ruthless’ pipeline prioritization, obesity and China: Three takeaways from AstraZeneca’s Q4
LONDON — AstraZeneca on Thursday morning teased its vision on how it could potentially enter the obesity market, as well as its views on further